jp morgan glp-1 JPM 2026] D&D Pharmatech chose MASH strategy different from Wegovy and Mounjaro < Pharma < Article Novo Nordisk sees pills capturing
Description
Despite definitive evidence suggesting that the triagonist offers a promising therapeutic option for the treatment of type 2 diabetes, the specific cellular mechanism by which the enhanced efficacy in glycaemic management is attained remains unclear
![jp morgan glp-1 JPM 2026] D&D Pharmatech chose MASH strategy different from Wegovy and Mounjaro < Pharma < Article Novo Nordisk sees pills capturing](https://www.reuters.com/resizer/v2/YJZ4KIHUGZJT7H3QS2FB5CHR74.jpg?auth=246b5a9fa5b4104fdb0c0356f167f972595d113e1fe02198f64e4682249b03ab&width=1080&quality=80)
High-profile chainsincluding Cuba Libre, Olive Garden, The Cheesecake Factory, and Chipotlehave begun offering GLP-1-friendly menus
Cmo y dnde comprar Ozempic en Espaa
![jp morgan glp-1 JPM 2026] D&D Pharmatech chose MASH strategy different from Wegovy and Mounjaro < Pharma < Article Novo Nordisk sees pills capturing](https://i.ytimg.com/vi/MN-XtUKlQDA/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLBDijEd6s4cIyhQ-LJGIzbDDKxx8Q)
Emerging research suggests GLP-1 medications may affect more than blood sugar and body weight
While GLP-1 agents alone rarely cause hypoglycemia due to their glucose-dependent mechanism, combination therapy increases this risk
![jp morgan glp-1 JPM 2026] D&D Pharmatech chose MASH strategy different from Wegovy and Mounjaro < Pharma < Article Novo Nordisk sees pills capturing](https://cdn.jpmorganfunds.com/content/dam/jpm-am-aem/americas/us/en/images/charts-graphs/obesity-article-r3-jb.png?v=1748873633852)